Patterns of cell signaling pathway activation that characterize mammary development

Development

Volumn 135, Issue 14, 2008, Pages 2403-2413

  Andrechek, Eran R ^a   Mori, Seiichi ^a   Rempel, Rachel E ^a   Chang, Jeffrey T ^a   Nevins, Joseph R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

E2F transcription factor; Mammary gland; Microarray; Mouse

Indexed keywords

MYC PROTEIN; PROTEIN TYROSINE KINASE; RAS PROTEIN; TRANSCRIPTION FACTOR E2F;

ANIMAL TISSUE; ARTICLE; BREAST DEVELOPMENT; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HISTOLOGY; INVOLUTION; LACTATION; METABOLIC ACTIVATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

MUS;

EID: 50249151374     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.019018     Document Type: Article

References (54)

1. Akhtar, N. and Streuli, C. H. (2006). Rac1 links integrin-mediated adhesion to the control of lactational differentiation in mammary epithelia. J. Cell Biol. 173, 781-793.
2. Beaton, A., Wilkins, R. J. and Wheeler, T. T. (1997). Lactation-associated and prolactin-responsive changes in protein synthesis in mouse mammary cells. Tissue Cell 29, 509-516.
3. Berenjeno, A. M., Nunez, F and Bustelo, X. R. (2007). Transcriptomal profiling of the cellular transformation induced by Rho subfamily GTPases. Oncogene 26, 4295-4305.
4. Bild, A., Yao, G., Chang, J. T., Wang, Q., Potti, A., Chasse, D., Joshi, M.-B., Harpole, D., Lancaster, J. M., Berchuck, A. et al. (2006). Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439, 353-357.
5. Black, E. P., Huang, E., Dressman, H., Ishida, S., West, M. and Nevins, J. R. (2003). Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Res. 63, 3716-3723.
6. Blakely, C. M., Sintasath, L., DCruz, C. M., Hahn, K. T., Dugan, K. D., Belka, G. K. and Chodosh, L. A. (2005). Developmental stage determines the effects of MYC in the mammary epithelium. Development 132, 1147-1160.
7. Blanchard, A., Shiu, R., Booth, S., Sorensen, G., DeCorby, N., Nistor, A., Wong, R, Leygue, E. and Myal, Y. (2007). Gene expression profiling of early involuting mammary gland reveals novel genes potentially relevant to human breast cancer. Front. Biosci. 12, 2221-2232.
8. Calvano, S. E., Xiao, W., Richards, D. R., Felciano, R. M., Baker, H. V., Cho, R. J., Chen, R. O., Brownstein, B. H., Cobb, J. R, Tschoeke, S. K. et al. (2005). A network-based analysis of systemic inflammation in humans. Nature 437, 1032-1037.
9. Chang, J. I and Nevins, J. R. (2006). GATHER: a systems approach to interpreting genomic signatures. Bioinformatics 22, 2926-2933.
10. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J. and Rutter, W. J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
11. Clarkson, R. W., Wayland, M. 1, Lee, J., Freeman, T. and Watson, C. J. (2004). Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res. 6, R92-R109.
12. Dauer, D. J., Ferraro, B., Song, L., Yu, B., Mora, L., Buettner, R., Enkemann, S. A., Jove, R. and Haura, E. B. (2005). Stat3 regulates genes common to both wound healing and cancer. Oncogene 24, 3397-3408.
13. DeGregori, J., Kowalik, T. and Nevins, J. R. (1995). Cellular targets for activation by the E2F1 transcription factor include DNA synthesis and G1/S regulatory genes. Mol. Cell. Biol. 15, 4215-4224.
14. Deome, K. B., Faulkin, L. J., Jr, Bern, H. A. and Blair, P. B. (1959). Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res. 19, 515-520.
15. Edelman, E., Porrello, A.. Guinney, J., Balakumaran, B., Bild, A., Febbo, P. G. and Mukherjee, S. (2006). Analysis of sample set enrichment scores: assaying the enrichment of sets of genes for individual samples in genome-wide expression profiles. Bioinformatics 22, e108-e116.
16. Field, S. J., Tsai, F.-Y., Kuo, F., Zubiaga, A. M., Kaelin, W. G., Jr, Livingston, D. M., Orkin, S. H. and Greenberg, M. E. (1996). E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549-561.
17. Gadd, M., Pisc, C., Branda, J., Ionescu-Tiba, V., Nikolic, Z., Yang, C., Wang, T., Shackleford, G. M., Cardiff, R. D. and Schmidt, E. V. (2001). Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution. Cancer Res. 61, 8811-8819.
18. Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pages, C., Tosolini, M., Camus, M., Berger, A., Wind, P. et al. (2006). Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960-1964.
19. Hallstrom, T. C. and Nevins, J. R. (2003). Specificity in the activation and control of transcription factor E2F-dependent apoptosis. Proc. Natl. Acad. Sci. USA 100, 10848-10853.
20. Huang, E., Ishida, S., Pittman, J., Dressman, H., West, M. and Nevins, J. R. (2003). Gene expression phenotypic models that predict the activity of oncogenic pathways. Nature Genet. 34, 226-230.
21. Huang, J. Q., Trasler, J. M., Igdoura, S., Michaud, J., Hanal, N. and Gravel, R. A. (1997). Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. Hum. Mol. Genet. 6, 1879-1885
22. Humbert, P. O., Verona, R., Trimarchi, J. M., Rogers, C., Dandapani, S. and Lees, J. A. (2000). E2f3 is critical for normal cellular proliferation. Genes Dev. 14, 690-703.
23. Jerry, D. J., Kuperwasser, C., Downing, S. R., Pinkas, J., He, C., Dickinson, E., Marconi, S. and Naber, S. P. (1998). Delayed involution of the mammary epithelium in BALB/c-p53null mice. Oncogene 17, 2305-2312.
24. Jhappan, C., Geiser, A. G., Kordon, E. C., Bagheri, D., Henninghausen, L., Roberts, A. B., Smith, G. H. and Merlino, G. (1993). Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J. 12, 1835-1845.
25. Kim, H. G., Laing, M. and Muller, W. (2005). c-Src-null mice exhibit defects in normal mammary gland development and ERalpha signaling. Oncogene 24, 5629-5636.
26. Kinross, K. M., Clark, A. J., Iazzolino, R. M. and Humbert, P. O. (2006). E2f4 regulates fetal erythropoiesis through the promotion of cellular proliferation. Blood 108, 886-895.
27. Kong, L.A., Chang, J. T., Bild, A. H. and Nevins, J. R. (2007). Compensation and specificity of function within the E2F family. Oncogene 26, 321-327.
28. Kouros-Mehr, H. and Werb, Z. (2006). Candidate regulators of mammary branching morphogenesis identified by genome-wide transcript analysis. Dev Dyn. 235, 3404-3412.
29. Kouros-Mehr, H., Slorach, E. M., Sternlicht, M. D. and Werb, Z. (2006). GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127, 1041-1055.
30. Kowalik, T. F., DeGregori, J., Schwarz, J. K. and Nevins, J. R. (1995). E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69, 2491-2500.
31. Kowalik, T. F., DeGregori, J., Leone, G. and Nevins, J. R. (1998). E2F1-specific induction of apoptosis and p53 accumulation is modulated by mdm2. Cell Growth Differ. 9, 113-118.
32. Li, M., Hu, J., Heermeier, K., Hennighausen, L. and Furth, P. A. (1996). Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways. Cell Growth Differ. 7, 13-20.
33. Locke, D., Stein, T., Davies, C., Morris, J., Harris, A. L., Evans, W. H., Monaghan, P. and Gusterson, B. (2004). Altered permeability and modulatory character of connexin channels during mammary gland development. Exp. Cell Res. 298, 643-660.
34. Master, S. R., Hartman, J. L., D'Cruz, C. M., Moody, S. E., Keiper, E. A., Ha, S. I., Cox, J. D., Belka, G. K. and Choclosh, L. A. (2002). Functional microarray analysis of mammary organogenesis reveals a developmental role in adaptive thermogenesis. Mol. Endocrinol. 16, 1185-1203.
35. Matthews, J. R. and Clarke, A. R. (2005). p53 mediates a default programme of mammary gland involution in the absence of STAT3. Oncogene 24, 3083-3090.
36. McBryan, J., Howlin, J., Kenny, R A., Shioda, T. and Martin, F. (2007). ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis. Oncogene 26, 6406-6419.
37. Murga, M., Fernandez-Capetillo, O., Field, S. J., Moreno, B., Borlaclo, L. R., Fujiwara, Y., Balomenos, D., Vicario, A., Carrera, A. C., Orkin, S. H. et al. (2001). Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 15, 959-970.
38. Rempel, R. E., Saenz-Robles, M. T., Storms, R., Morham, S., Ishida, S., Engel, A., Jakol, L., Melhem, M. F., Pipas, J. M., Smith, C. et al. (2000). Loss of E2F4 activity leads to abnormal development of multiple cellular lineages. Mol. Cell 6, 293-306.
39. Renzoni, E. A., Abraham, D. J., Howat, S., Shi-Wen, X., Sestini, P., Bou-Gharios, G., Wells, A. U., Veeraraghavan, S., Nicholson, A. G., Denton, C. P. et al. (2004). Gene expression profiling reveals novel TGFbeta targets in adult lung fibroblasts. Respir. Res. 5, 24.
40. Robinson, S. D., Roberts, A. B. and Daniel, C. W. (1993). TGF-beta suppresses casein synthesis in mouse mammary explants and may play a role in controlling milk levels during pregnancy. J. Cell Biol. 120, 245-251.
41. Rudolph, M. C., McManaman, J. L., Phang, T., Russell, T., Kominsky, D. J., Serkova, N. J., Stein, T., Anderson, S. M. and Neville, M. C. (2007). Metabolic regulation in the lactating mammary gland: a lipid synthesizing machine. Physiol. Genomics 28, 323-336.
42. Smolenski, G., Haines, S., Kwan, F. Y., Bond, J., Farr, V., Davis, S. R., Stelwagen, K. and Wheeler, T. T. (2007). Characteristisation of host defence proteins in milk using a proteomic approach. J. Proteome Res. 6, 207-215.
43. Stein, T., Morris, J. S., Davies, C. R., Weber-Hall, S. J., Duffy, M. A., Heath, V. J., Bell, A. K., Ferrier, R. K., Sandilands, G. P. and Gusterson, B. A. (2004). Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14, and STAT3. Breast Cancer Res. 6, 89-92.
44. Stein, T., Price, K. N., Morris, J. S., Heath, V. J., Ferrier, R. K., Bell, A. K., Pringle, M. A., Villadsen, R., Petersen, O. W., Sauter, G. et al. (2005). Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer. Clin. Cancer Res. 11, 6872-6879.
45. Subramanian, A., Tamayo, R, Mootha, V. K., Mukherjee, S., Ebert, B. L., Gilletee, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S. et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550.
46. Takekawa, M. and Saito, H. (1998). A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/ MEKK4 MAPKKK. Cell 95, 521-530.
47. Tomasini, R., Seux, M., Nowak, J., Bontemps, C., Carrier, A., Dagorn, J. C., Pebusque, M. J., lovanna, J. L. and Dusetti, N. J. (2005). TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity. Oncogene 24, 8093-8204.
48. Tsai, K. Y., Hu, Y., Macleod, K. F., Crowley, D., Yamasaki, L. and Jacks, T. (1998). Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-cleficient mouse embryos. Mol. Cell 2, 293-304.
49. Varela, L. M. and Ip, M. M. (1996). Tumor necrosis factor-alpha: a multifunctional regulator of mammary gland development. Endocrinology 137, 4915-4924.
50. Viemann, D., Goebeler, M., Schmid, S., Nordhues, U., Klimmek, K., Sorg, C. and Roth, J. (2006). TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells. J. Leukoc. Biol. 80, 174-185.
51. Vorbach, C., Capecchi, M. R. and Penninger, J. M. (2006). Evolution of the mammary gland from the innate immune system? BioEssays 28, 606-616.
52. Webster, M. A., Cardiff, R. D. and Muller, W. J. (1995). Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene. Proc. Natl. Acad. Sci. USA 92, 7849-7853.
53. Zhu, W., Giangrande, R and Nevins, J. R. (2004). E2Fs link the control of G1/S and G2/M. EMBO J. 23, 4615-4626.
54. Ziebold, U., Reza, T., Caron, A. and Lees, J. A. (2001). E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev. 15, 386-391.